vs

Side-by-side financial comparison of ResMed (RMD) and Roper Technologies (ROP). Click either name above to swap in a different company.

Roper Technologies is the larger business by last-quarter revenue ($2.1B vs $1.4B, roughly 1.5× ResMed). ResMed runs the higher net margin — 27.6% vs 15.8%, a 11.8% gap on every dollar of revenue. On growth, Roper Technologies posted the faster year-over-year revenue change (11.3% vs 11.0%). Over the past eight quarters, Roper Technologies's revenue compounded faster (10.5% CAGR vs 7.9%).

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

RMD vs ROP — Head-to-Head

Bigger by revenue
ROP
ROP
1.5× larger
ROP
$2.1B
$1.4B
RMD
Growing faster (revenue YoY)
ROP
ROP
+0.3% gap
ROP
11.3%
11.0%
RMD
Higher net margin
RMD
RMD
11.8% more per $
RMD
27.6%
15.8%
ROP
Faster 2-yr revenue CAGR
ROP
ROP
Annualised
ROP
10.5%
7.9%
RMD

Income Statement — Q4 FY2026 vs Q1 FY2026

Metric
RMD
RMD
ROP
ROP
Revenue
$1.4B
$2.1B
Net Profit
$392.6M
$331.0M
Gross Margin
61.8%
69.4%
Operating Margin
34.6%
27.2%
Net Margin
27.6%
15.8%
Revenue YoY
11.0%
11.3%
Net Profit YoY
13.9%
53.7%
EPS (diluted)
$2.68
$4.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RMD
RMD
ROP
ROP
Q2 26
$1.4B
Q1 26
$2.1B
Q4 25
$1.4B
$2.1B
Q3 25
$1.3B
$2.0B
Q2 25
$1.3B
$1.9B
Q1 25
$1.3B
$1.9B
Q4 24
$1.3B
$1.9B
Q3 24
$1.2B
$1.8B
Net Profit
RMD
RMD
ROP
ROP
Q2 26
$392.6M
Q1 26
$331.0M
Q4 25
$392.6M
$428.4M
Q3 25
$348.5M
$398.5M
Q2 25
$379.7M
$378.3M
Q1 25
$365.0M
$331.1M
Q4 24
$344.6M
$462.3M
Q3 24
$311.4M
$367.9M
Gross Margin
RMD
RMD
ROP
ROP
Q2 26
61.8%
Q1 26
69.4%
Q4 25
61.8%
69.5%
Q3 25
61.5%
69.5%
Q2 25
60.8%
69.2%
Q1 25
59.3%
68.7%
Q4 24
58.6%
68.3%
Q3 24
58.6%
69.2%
Operating Margin
RMD
RMD
ROP
ROP
Q2 26
34.6%
Q1 26
27.2%
Q4 25
34.6%
28.6%
Q3 25
33.4%
28.4%
Q2 25
33.7%
28.2%
Q1 25
33.0%
27.9%
Q4 24
32.5%
28.0%
Q3 24
31.6%
28.1%
Net Margin
RMD
RMD
ROP
ROP
Q2 26
27.6%
Q1 26
15.8%
Q4 25
27.6%
20.8%
Q3 25
26.1%
19.8%
Q2 25
28.2%
19.5%
Q1 25
28.3%
17.6%
Q4 24
26.9%
24.6%
Q3 24
25.4%
20.8%
EPS (diluted)
RMD
RMD
ROP
ROP
Q2 26
$2.68
Q1 26
$4.87
Q4 25
$2.68
$3.97
Q3 25
$2.37
$3.68
Q2 25
$2.58
$3.49
Q1 25
$2.48
$3.06
Q4 24
$2.34
$4.29
Q3 24
$2.11
$3.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RMD
RMD
ROP
ROP
Cash + ST InvestmentsLiquidity on hand
$1.4B
$382.9M
Total DebtLower is stronger
$663.8M
$9.7B
Stockholders' EquityBook value
$6.3B
$18.8B
Total Assets
$8.5B
$34.6B
Debt / EquityLower = less leverage
0.11×
0.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RMD
RMD
ROP
ROP
Q2 26
$1.4B
Q1 26
$382.9M
Q4 25
$1.4B
$297.4M
Q3 25
$1.4B
$320.0M
Q2 25
$1.2B
$242.4M
Q1 25
$932.7M
$372.8M
Q4 24
$521.9M
$188.2M
Q3 24
$426.4M
$269.6M
Total Debt
RMD
RMD
ROP
ROP
Q2 26
$663.8M
Q1 26
$9.7B
Q4 25
$403.9M
$9.3B
Q3 25
$408.7M
Q2 25
$658.4M
Q1 25
$663.1M
Q4 24
$662.9M
$7.6B
Q3 24
$667.6M
Stockholders' Equity
RMD
RMD
ROP
ROP
Q2 26
$6.3B
Q1 26
$18.8B
Q4 25
$6.3B
$19.9B
Q3 25
$6.1B
$20.0B
Q2 25
$6.0B
$19.6B
Q1 25
$5.5B
$19.2B
Q4 24
$5.3B
$18.9B
Q3 24
$5.2B
$18.5B
Total Assets
RMD
RMD
ROP
ROP
Q2 26
$8.5B
Q1 26
$34.6B
Q4 25
$8.5B
$34.6B
Q3 25
$8.3B
$34.6B
Q2 25
$8.2B
$33.2B
Q1 25
$7.6B
$31.4B
Q4 24
$7.1B
$31.3B
Q3 24
$7.2B
$31.6B
Debt / Equity
RMD
RMD
ROP
ROP
Q2 26
0.11×
Q1 26
0.52×
Q4 25
0.06×
0.47×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.12×
Q4 24
0.13×
0.40×
Q3 24
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RMD
RMD
ROP
ROP
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$507.0M
FCF MarginFCF / Revenue
24.2%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RMD
RMD
ROP
ROP
Q2 26
Q1 26
Q4 25
$339.7M
$738.0M
Q3 25
$457.3M
$869.5M
Q2 25
$538.8M
$404.1M
Q1 25
$578.7M
$528.7M
Q4 24
$308.6M
$722.2M
Q3 24
$325.5M
$755.4M
Free Cash Flow
RMD
RMD
ROP
ROP
Q2 26
Q1 26
$507.0M
Q4 25
$311.2M
Q3 25
$414.4M
Q2 25
$508.2M
Q1 25
$557.9M
Q4 24
$288.0M
Q3 24
$307.7M
FCF Margin
RMD
RMD
ROP
ROP
Q2 26
Q1 26
24.2%
Q4 25
21.9%
Q3 25
31.0%
Q2 25
37.7%
Q1 25
43.2%
Q4 24
22.5%
Q3 24
25.1%
Capex Intensity
RMD
RMD
ROP
ROP
Q2 26
Q1 26
0.5%
Q4 25
2.0%
Q3 25
3.2%
Q2 25
2.3%
Q1 25
1.6%
Q4 24
1.6%
Q3 24
1.5%
Cash Conversion
RMD
RMD
ROP
ROP
Q2 26
Q1 26
Q4 25
0.87×
1.72×
Q3 25
1.31×
2.18×
Q2 25
1.42×
1.07×
Q1 25
1.59×
1.60×
Q4 24
0.90×
1.56×
Q3 24
1.05×
2.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons